Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema [Corrigendum]
Authors Qingyu L, He M, Shi H, Wang Q, Du Y, Liu J, Ren C, Xu D, Jing Y
Received 21 March 2016
Accepted for publication 21 March 2016
Published 27 April 2016 Volume 2016:10 Pages 1547—1548
Liu QY, He MM, Shi H, et al. Drug Des Devel Ther. 2015;9: 2527–2535.
In “Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials” published May 2015, on page 2530, in Table 1 we have mistakenly stated the fluocinolone acetonide (FA) intravitreal inserts as Retisert® in the Campochiaro et al study; they were in fact the fluocinolone acetonide intravitreal inserts. We feel sorry about that, and we will be more rigorous to avoid any unnecessary confusion in the future.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]